Effect of Vitamin E Fortified Whey Drink on Nutritional, Inflammatory and Oxidative Markers in Hemodialysis Patients
NCT02163070 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 92
Last updated 2015-01-09
Summary
The purpose of the study is to evaluate the effect of vitamin E fortified whey drink on nutritional status, inflammatory markers and oxidative stress in hemodialysis patients
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
whey drink,
consumption of 220 milliliters of whey drink three times a week,
- DIETARY_SUPPLEMENT
-
whey drink fortified with vitaminE
consumption of 220 milliliters of whey drink fortified with 400 milligrams of vitamin E three times a week,
- DIETARY_SUPPLEMENT
-
vitamin E
consumption of 400 milligrams of vitamin E three times a week,
Sponsors & Collaborators
-
Shiraz University of Medical Sciences
collaborator OTHER -
Mohammad Hassan Eftekhari
lead OTHER
Principal Investigators
-
Mohammad Hassan Eftekhari, professor · Shiraz University of Medical Sciences
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 17 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-09-30
- Primary Completion
- 2014-03-31
- Completion
- 2014-06-30
More Related Trials
-
The Effects of Dietary Fiber in CKD: A Systematic Review and Meta-analysis
NCT01844882 ·Status: COMPLETED
-
KPs Supplement for Inflammation, Oxidative Stress and Lipid Abnormalities in CKD Patients.
NCT07260292 ·Status: COMPLETED ·Phase: NA
-
Long-Term Effect of Soy Consumption on Cardio-Renal Indices and CRP in Type 2diabetes With Nephropathy
NCT00555490 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Multiple Mega-dose of Vitamin D3 Supplementation on Ameliorating Moderate to Severe Chronic Pain in Hemodialysis Patients
NCT05667090 ·Status: RECRUITING ·Phase: NA
-
Differential Effects of Ergocalciferol and Cholecalciferol Therapies in Chronic Kidney Disease
NCT01835691 ·Status: COMPLETED ·Phase: NA
-
Protein, Nutrition and Cardiovascular Disease in Stage 5 Chronic Kidney Disease
NCT00566670 ·Status: COMPLETED
-
Soy Protein in Early Diabetic Nephropathy
NCT00067678 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V
NCT03565913 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Effect of Protein Restriction Plus EAA/KA Supplementation on GFR Decline in CKD
NCT05952544 ·Status: COMPLETED
-
Pharmacokinetic Comparison of Vitamin's D2 and D3 in Stage 5 Chronic Kidney Disease Patients on Chronic Hemodialysis
NCT01675557 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) Patients
NCT01061320 ·Status: UNKNOWN ·Phase: PHASE3
-
Impact of Vitamin D Therapies on Chronic Kidney Disease
NCT01222234 ·Status: COMPLETED ·Phase: NA
-
Study of Vitamin C, Vitamin E and Their Combination to Treat Restless Legs Syndrome in Hemodialysis Patients
NCT01125033 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Keto-/Amino Acid Supplemented Low Protein Diet in Patients With Chronic Kidney Disease
NCT00364884 ·Status: UNKNOWN ·Phase: PHASE4
-
Oxidative Stress and Hemodialysis Access Failure
NCT00410449 ·Status: COMPLETED
-
The Effects of Isoflavones on Cardiovascular and Bone Metabolism Markers in Peritoneal Dialysis Patients
NCT03773029 ·Status: UNKNOWN ·Phase: NA
-
Effect of Selenium Supplementation on Inflammatory,Oxidative and Nutritional Markers in Hemodialysis Patients
NCT01147354 ·Status: COMPLETED ·Phase: PHASE3
-
Vitamin D Supplement Study for Stage Three and Four Chronic Kidney Disease (CKD) Patients
NCT01173848 ·Status: TERMINATED ·Phase: PHASE3
-
Low-protein Formula Supplements in Chronic Kidney Disease
NCT05318014 ·Status: COMPLETED ·Phase: NA
-
Effect of Vitamin E+Selenium on Kidney Function in Controlled Hypotension
NCT01554345 ·Status: UNKNOWN ·Phase: PHASE2
-
Role of Extrarenal 1-Alpha-Hydroxylase in Patients With End Stage Renal Disease
NCT00677534 ·Status: COMPLETED ·Phase: NA
-
Identification of Markers for Determining the Efficacy of Vitamin D Receptor Activator Therapy in Stage 3/4 CKD Patients
NCT02018133 ·Status: COMPLETED
-
Relationship Between Serum 1,25-dihydroxy Vitamin D and Markers of Bone Metabolism in Renal Dysfunction Patients
NCT05399251 ·Status: COMPLETED
-
Impact of Vitamin D on Endothelial Function and Blood Biomarkers Including CD28 Null Cells in CKD
NCT02005718 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
NCT02888171 ·Status: COMPLETED ·Phase: NA